Cost savings of reducing opioid prescribing for the treatment of people with low back pain in general practice: a modelling studyResearch in context

Summary: Background: Low back pain (LBP) is the leading cause of disability worldwide. Contrary to clinical guidelines, opioids are frequently prescribed early in the management of LBP in primary care, leading to potential harm and downstream healthcare costs. The objective of this study was to mod...

Full description

Saved in:
Bibliographic Details
Main Authors: Anagha Killedar, Romi Haas, Alexandra Gorelik, Sean Docking, Rachelle Buchbinder, Chris G. Maher, Chung-Wei Christine Lin, Alison Hayes
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:The Lancet Regional Health. Western Pacific
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666606524002712
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841545516479938560
author Anagha Killedar
Romi Haas
Alexandra Gorelik
Sean Docking
Rachelle Buchbinder
Chris G. Maher
Chung-Wei Christine Lin
Alison Hayes
author_facet Anagha Killedar
Romi Haas
Alexandra Gorelik
Sean Docking
Rachelle Buchbinder
Chris G. Maher
Chung-Wei Christine Lin
Alison Hayes
author_sort Anagha Killedar
collection DOAJ
description Summary: Background: Low back pain (LBP) is the leading cause of disability worldwide. Contrary to clinical guidelines, opioids are frequently prescribed early in the management of LBP in primary care, leading to potential harm and downstream healthcare costs. The objective of this study was to model the one-year impacts of strategies that reduce opioid prescribing for low back pain (LBP) in primary care on healthcare costs and overdose deaths Australia-wide and explore the potential for such strategies to be cost-neutral. Methods: Two decision tree models were developed: the healthcare actions model, which tracked post-diagnosis care pathways, and the opioid overdose model, which modelled overdoses and consequent healthcare costs and deaths, following opioid prescribing. These models were developed using data from the electronic medical records of 65,612 LBP patients from general practices in Victoria, Australia and from published literature. Healthcare costs and change in overdose deaths associated with strategies delivering 0–100% relative reduction in opioid prescribing for LBP in primary care were estimated with a one-year time horizon. The relative reduction in opioid prescription needed for a strategy to be cost-neutral was also calculated. Findings: A relative 20% reduction in opioid prescribing was estimated to save $5.41 million due to changes to downstream care, save $2.24 million due to avoided opioid overdoses and prevent 81 overdose deaths nationally, over one year. A relative reduction in opioid prescribing of 1.2% and 10.3% would be needed to recoup the costs of a strategy costing $500,000 and $4 million, respectively, over one year. Interpretation: The study highlights the short-term health and economic benefits of reducing opioid prescribing for LBP and suggests that a low to medium intensity strategy could be cost-neutral or cost-saving. Funding: This study was funded by the National Health and Medical Research Council of Australia.
format Article
id doaj-art-7e8e58f9d9a34105a7f4760cde39a479
institution Kabale University
issn 2666-6065
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series The Lancet Regional Health. Western Pacific
spelling doaj-art-7e8e58f9d9a34105a7f4760cde39a4792025-01-12T05:25:54ZengElsevierThe Lancet Regional Health. Western Pacific2666-60652025-01-0154101277Cost savings of reducing opioid prescribing for the treatment of people with low back pain in general practice: a modelling studyResearch in contextAnagha Killedar0Romi Haas1Alexandra Gorelik2Sean Docking3Rachelle Buchbinder4Chris G. Maher5Chung-Wei Christine Lin6Alison Hayes7Leeder Centre for Health Policy, Economics and Data, School of Public Health, Faculty of Medicine and Health, University of Sydney, NSW, 2006, Australia; School of Public Health, Faculty of Medicine and Health, University of Sydney, NSW, 2006, Australia; Corresponding author. Level 5, Moore College CG2, 1 King Street, Newtown, NSW, 2042, Australia.Musculoskeletal Health and Wiser Health Care Units, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, 3004, AustraliaMusculoskeletal Health and Wiser Health Care Units, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, 3004, AustraliaMusculoskeletal Health and Wiser Health Care Units, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, 3004, AustraliaMusculoskeletal Health and Wiser Health Care Units, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, 3004, AustraliaSchool of Public Health, Faculty of Medicine and Health, University of Sydney, NSW, 2006, Australia; Institute for Musculoskeletal Health, Sydney Local Health District, Sydney, NSW, AustraliaSchool of Public Health, Faculty of Medicine and Health, University of Sydney, NSW, 2006, Australia; Institute for Musculoskeletal Health, Sydney Local Health District, Sydney, NSW, AustraliaSchool of Public Health, Faculty of Medicine and Health, University of Sydney, NSW, 2006, AustraliaSummary: Background: Low back pain (LBP) is the leading cause of disability worldwide. Contrary to clinical guidelines, opioids are frequently prescribed early in the management of LBP in primary care, leading to potential harm and downstream healthcare costs. The objective of this study was to model the one-year impacts of strategies that reduce opioid prescribing for low back pain (LBP) in primary care on healthcare costs and overdose deaths Australia-wide and explore the potential for such strategies to be cost-neutral. Methods: Two decision tree models were developed: the healthcare actions model, which tracked post-diagnosis care pathways, and the opioid overdose model, which modelled overdoses and consequent healthcare costs and deaths, following opioid prescribing. These models were developed using data from the electronic medical records of 65,612 LBP patients from general practices in Victoria, Australia and from published literature. Healthcare costs and change in overdose deaths associated with strategies delivering 0–100% relative reduction in opioid prescribing for LBP in primary care were estimated with a one-year time horizon. The relative reduction in opioid prescription needed for a strategy to be cost-neutral was also calculated. Findings: A relative 20% reduction in opioid prescribing was estimated to save $5.41 million due to changes to downstream care, save $2.24 million due to avoided opioid overdoses and prevent 81 overdose deaths nationally, over one year. A relative reduction in opioid prescribing of 1.2% and 10.3% would be needed to recoup the costs of a strategy costing $500,000 and $4 million, respectively, over one year. Interpretation: The study highlights the short-term health and economic benefits of reducing opioid prescribing for LBP and suggests that a low to medium intensity strategy could be cost-neutral or cost-saving. Funding: This study was funded by the National Health and Medical Research Council of Australia.http://www.sciencedirect.com/science/article/pii/S2666606524002712OpioidsLow back painHealthcare savingsCost savingsGeneral practiceEconomic modelling
spellingShingle Anagha Killedar
Romi Haas
Alexandra Gorelik
Sean Docking
Rachelle Buchbinder
Chris G. Maher
Chung-Wei Christine Lin
Alison Hayes
Cost savings of reducing opioid prescribing for the treatment of people with low back pain in general practice: a modelling studyResearch in context
The Lancet Regional Health. Western Pacific
Opioids
Low back pain
Healthcare savings
Cost savings
General practice
Economic modelling
title Cost savings of reducing opioid prescribing for the treatment of people with low back pain in general practice: a modelling studyResearch in context
title_full Cost savings of reducing opioid prescribing for the treatment of people with low back pain in general practice: a modelling studyResearch in context
title_fullStr Cost savings of reducing opioid prescribing for the treatment of people with low back pain in general practice: a modelling studyResearch in context
title_full_unstemmed Cost savings of reducing opioid prescribing for the treatment of people with low back pain in general practice: a modelling studyResearch in context
title_short Cost savings of reducing opioid prescribing for the treatment of people with low back pain in general practice: a modelling studyResearch in context
title_sort cost savings of reducing opioid prescribing for the treatment of people with low back pain in general practice a modelling studyresearch in context
topic Opioids
Low back pain
Healthcare savings
Cost savings
General practice
Economic modelling
url http://www.sciencedirect.com/science/article/pii/S2666606524002712
work_keys_str_mv AT anaghakilledar costsavingsofreducingopioidprescribingforthetreatmentofpeoplewithlowbackpainingeneralpracticeamodellingstudyresearchincontext
AT romihaas costsavingsofreducingopioidprescribingforthetreatmentofpeoplewithlowbackpainingeneralpracticeamodellingstudyresearchincontext
AT alexandragorelik costsavingsofreducingopioidprescribingforthetreatmentofpeoplewithlowbackpainingeneralpracticeamodellingstudyresearchincontext
AT seandocking costsavingsofreducingopioidprescribingforthetreatmentofpeoplewithlowbackpainingeneralpracticeamodellingstudyresearchincontext
AT rachellebuchbinder costsavingsofreducingopioidprescribingforthetreatmentofpeoplewithlowbackpainingeneralpracticeamodellingstudyresearchincontext
AT chrisgmaher costsavingsofreducingopioidprescribingforthetreatmentofpeoplewithlowbackpainingeneralpracticeamodellingstudyresearchincontext
AT chungweichristinelin costsavingsofreducingopioidprescribingforthetreatmentofpeoplewithlowbackpainingeneralpracticeamodellingstudyresearchincontext
AT alisonhayes costsavingsofreducingopioidprescribingforthetreatmentofpeoplewithlowbackpainingeneralpracticeamodellingstudyresearchincontext